NCT06267313

Attention Training for COVID-19 Related Distress

Name: Clinical Trial NCT06267313
Creator: Palo Alto University
Keywords: Anxiety, Attention Bias Modification, behavioral, clinical trial

Palo Alto University·ClinicalTrials.gov·behavioralNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Anxiety
Drug/Device/Intervention: Attention Bias Modification
Study type: Interventional
Intervention type: behavioral

Sponsor & location

Primary sponsor: Palo Alto University

Timeline & enrollment

Phase: N/A
Start date: Feb 19, 2024
End date: Feb 19, 2026
Enrollment: 200 participants

Primary outcome

COVID-19 Anxiety Syndrome Scale,COVID-19 Anxiety Syndrome Scale,COVID-19 Anxiety Syndrome Scale,COVID-19 Anxiety Syndrome Scale

Summary

The study aims to test whether attention training (attention bias modification or attention control training) reduces distress or COVID-19 related anxiety compared to a neutral condition.

ICD-10 classifications

Anxiety disorder, unspecifiedOther anxiety disordersPhobic anxiety disordersPhobic anxiety disorder, unspecifiedGeneralized anxiety disorder

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06267313
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06267313 through Pure Global AI's free database. This phase not specified trial is sponsored by Palo Alto University and is currently Not yet recruiting. The study focuses on Anxiety. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.